SCHEMBL1921339

SCHEMBL1921339

CC(CC=O)OC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL87648 0.80
SCHEMBL27738429 0.80
SCHEMBL27717369 0.80
SCHEMBL995740 0.79
SCHEMBL18987284 0.78 LMNA (0.48)
SCHEMBL6543496 0.78 LMNA (0.48)
SCHEMBL28765755 0.78 LMNA (0.48)
SCHEMBL9451858 0.76 MEN1 (0.34)
SCHEMBL417149 0.76 CYP19A1 (0.33)
SCHEMBL29728566 0.75 TSHR (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035360-A1 INHIBITORS OF MYC AND USES THEREOF UNIV NORTHWESTERN (US) 2026-02-05 US disclosed
CN-113272309-B Tricyclic inhibitors of hepatitis b virus 圣拉斐尔医院有限公司 2024-02-23 CN disclosed
EP-2988597-B1 MACROLIDES AND METHODS OF THEIR PREPARATION AND USE HARVARD COLLEGE (US) 2022-06-08 EP disclosed
CN-110475777-B Novel pyrido [2,3-b ] indole compounds for the treatment and prevention of bacterial infections 豪夫迈·罗氏有限公司 2022-04-15 CN disclosed
CN-114173824-A Antibody drug conjugates 武田药品工业株式会社 2022-03-11 CN disclosed
US-10913764-B2 Macrolides and methods of their preparation and use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2021-02-09 US disclosed
US-20180298048-A1 MACROLIDES AND METHODS OF THEIR PREPARATION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-10-18 US disclosed
US-9982005-B2 Macrolides and methods of their preparation and use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-05-29 US disclosed
EP-2988597-A2 MACROLIDES AND METHODS OF THEIR PREPARATION AND USE President and Fellows of Harvard College (US) 2016-03-02 EP disclosed
US-20160052951-A1 MACROLIDES AND METHODS OF THEIR PREPARATION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-02-25 US disclosed
EP-2327705-B1 Podophyllotoxins as antiproliferative agents UNIVERSITÄTSKLINIKUM CHARITÉ DER HUMBOLDT UNIVERSITÄT ZU BERLIN (DE) 2015-05-27 EP disclosed
WO-2014165792-A2 MACROLIDES AND METHODS OF THEIR PREPARATION AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-10-09 WO disclosed
EP-2327705-A1 Podophyllotoxins as antiproliferative agents Universitätsklinikum Charité der Humboldt- Universität zu Berlin (DE) 2011-06-01 EP disclosed
EP-1451193-B1 PODOPHYLLOTOXINS AS ANTIPROLIFERATIVE AGENTS UNIVERSITAETSKLINIKUM CHARITE (DE) 2010-10-06 EP disclosed
US-7582778-B2 Podophyllotoxin UNIVERSITATSKLINIKUM CHARITE DER HUMBOLDT-UNIVERSITAT ZU (DE) 2009-09-01 US disclosed
US-20060293254-A1 enzyme inhibitors of topoisomerase as anticancer, antitumor, antifungal and/or microbiocides; ; etoposide and teniposide; prodrugs; water solubility, stability UNIVERSITATSKLINIKUM CHARITE DER HUMBOLDT-UNIVERSITAT ZU (DE) 2006-12-28 US disclosed
EP-1451193-A1 PODOPHYLLOTOXINS AS ANTIPROLIFERATIVE AGENTS Universitätsklinikum Charité der Humboldt- Universität zu Berlin (DE) 2004-09-01 EP disclosed
WO-2003048166-A1 PODOPHYLLOTOXINS AS ANTIPROLIFERATIVE AGENTS UNIVERSITÄTSKLINIKUM CHARITE DER HUMBOLDT-UNIVERSITÄT ZU BERLIN TECHNOLOGIE TRANSFERSTELLE (DE) 2003-06-12 WO disclosed